Demand Media Inc. (NYSE:DMD) on Thursday reported a loss of $14.4 million in its second quarter. On a per-share basis, the Santa Monica, California-based company said it had a loss of 73 cents. Losses, adjusted for non-recurring costs and pretax expenses, were 24 cents per share. Demand Media, Inc. (NYSE:DMD) belongs to Technology sector. Its weekly performance is -13.28%. On last trading day company shares ended up $5.16. Demand Media, Inc. (NYSE:DMD) distance from 50-day simple moving average (SMA50) is -13.63%.
On 5 August, CBS Corporation (NYSE:CBS) saw its second-quarter net earnings slip 24 percent to $332 million, while revenue was up 1 percent to $3.22 billion. Each of the company’s major segments posted revenue declines, with the exception of cable. Cable networks revenues were $615 million for the second quarter, up 19 percent from the same prior-year period, primarily driven by the distribution of Showtime’s pay-per-view boxing event. CBS Corporation (NYSE:CBS) shares moved down -3.64% in last trading session and ended the day at $50.34. CBS Gross Margin is 41.00% and its return on assets is 11.80%. CBS Corporation (NYSE:CBS) quarterly performance is -17.03%.
On 5 August, Fate Therapeutics Inc. (NASDAQ:FATE) reported a loss of $7.8 million in its second quarter. The San Diego-based company said it had a loss of 33 cents per share. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.On 07 August, Fate Therapeutics, Inc. (NASDAQ:FATE) shares increased 4.99% and was closed at $7.16. Fate Therapeutics, Inc. (NASDAQ:FATE) year to date (YTD) performance is 42.35%.
PrimeEnergy Corp. (NASDAQ:PNRG) ended the last trading day at $56.95. Company weekly volatility is calculated as 1.04% and price to cash ratio as 23.08. PrimeEnergy Corp. (NASDAQ:PNRG) showed a weekly performance of -2.23%.
Morgan & Morgan announces that a shareholder class action has been filed in the Delaware Court of Chancery against the Board of Directors of Receptos, Inc. (NASDAQ:RCPT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Celgene Corporation (“Celgene”).Receptos, Inc. (NASDAQ:RCPT) shares increased 0.24% in last trading session and ended the day at $228.55. RCPT return on assets is -26.50%. Receptos, Inc. (NASDAQ:RCPT) quarterly performance is 48.54%.